OWC Pharmaceutical Research Corp (OWCP)

[Potvinsux]

I am in the medical field and know medications (USA based), regardless of what they're indicated for, how well they work, what side effects they cause, are still used due to their FDA approval. FDA approval, although expensive and drawn out, does provide the medical community with confidence to give 'X' drug to patients.

OWCP will take the FDA route, but more importantly, are currently in the Israeli equivalent. Not one company, selling CBD cream, has done this. Don't forget, USA market is just a very small piece to the puzzle. That's why it's absurd for pps to drop so much after Sessions announcement.


From OWCP website:

The Company is committed to and the highest standards of integrity and ethics in proposing, conducting and reporting research. All its investigations and researches are conducted at the facilities of leading Israeli medical centers, as well as at the labs of the R&D pharmaceutical companies we contracted with. The Company adheres to all the necessary regulatory requirements, including submitting its research protocols to Ethics Committee (IRB) approval.

When it comes to medical cannabis, OWC believes in science instead of mythology.

We aim to produce pharmaceutical-grade cannabis-based products and treatments that are:-

Standardized in composition, formulation and dose;

Administered by means of the appropriate and efficient innovative delivery systems; and –

Tested in properly controlled pre-clinical and clinical studies.

We believe that its planned products will provide physicians with the ability to control and administrate optimal dosage, and to replace the common usage of medical cannabis today, which is not acceptable by scientists and physicians, such as smoking, edibles and oil extracts with no substantial dosage control.

We also believe that our planned products will provide patients with the absolute assurance that they are purchasing and taking products that are clinically tested, safe, efficient and consistent.